11. Den Hollander JA, Buchthal SD. Observation of GABA at 1.5 Tesla in 21.
the human brain using J-resolved localized 1H-NMR spectroscopy.
ISMRM Abstracts 1997; 1353.
12. Mattson RH, Petroff OAC, Rothman DL, Behar KL. Vigabatrin: effects of 22.
human brain GABA levels by nuclear magnetic resonance spectroscopy. Epilepsia 1994; 35:S29–S32. 23.
13. Petroff OAC, Rothman DL, Behar KL, Mattson RH. Initial observation on
24.
effect of vigabatrin on in vivo 1H spectroscopic measurements of
g-aminobutyric acid, glutamate, and glutamine in human brain. Epilepsia 1995; 36:457–464.
14. Petroff OAC, Behar KL, Mattson RH, Rothman DL. Human brain
25.
g-aminobutyric acid levels and seizure control following initiation of
vigabatrin therapy. J Neurochem 1996; 67:2399–2404.
15. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in
26.
three dimensions. Proc Natl Acad Sci USA 1982; 79:3523–3526.
16. Hetherington HP, Kuzniecky R, Pan JW, Mason G, Morawetz R, Harris C,
Faught E, Vaughan T, Pohost G. Proton nuclear magnetic resonance
27.
spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann
Neurol 1995; 38:396–404.
17. Sorensen OW, Eich GW, Levitt MH, Bodenhausen G, Ernst RR. Product 28.
operator formalism for the description of NMR pulse experiments. Prog
NMR Spectr 1983; 16:163–192.
18. Bodenhausen G, Kogler H, Ernst RR. Selection of coherence-transfer
pathways in NMR pulse experiments. J Magn Reson 1984; 58:370–388. 29.
19. Chen W, Ackerman JJH. Surface coil spin-echo localization in vivo via
inhomogeneous surface spoiling magnetic gradient. Nucl Magn Reson
Biomed 1989; 91:205–207. 30.
Shen J, Rycyna RE, Rothman DL. Improvements on an in vivo automatic
shimming method (FASTERMAP). Magn Reson Med 1997; 38:834–839.
